Associate Director, Content Enablement Platforms

Cambridge, MA (On-site)

$172K/yr – $233K/yrSenior Level7+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive day-to-day CMS publishing, governance, and issue resolution for Alnylam’s global web platforms at an Associate Director level.

  • Owns publishing activities, QA, and release support across global markets.
  • Must have 7–10+ years in enterprise CMS in regulated environments and hands-on AEM/Sitecore/Drupal experience.

Standout collaboration with IT, Marketing Operations, and agencies ensures scalable, compliant publishing and governance.

Job Description

Responsibilities

  • Execute and support day-to-day CMS publishing activities, including content updates, page builds, workflow execution, and release support.
  • Monitor platform health, publishing queues, and execution timelines; identify and resolve issues before they impact markets.
  • Perform and coordinate QA activities, including functional checks, accessibility validation, metadata accuracy, and content integrity.
  • Troubleshoot publishing and workflow issues in partnership with agencies and IT, clearly distinguishing execution issues from technical defects.
  • Apply and reinforce publishing governance standards related to templates, metadata, tagging, accessibility, and approved workflows.
  • Partner closely with Marketing Operations, who own the DAM platform, to support integration between DAM and CMS workflows and enable effective asset reuse across markets.
  • Work directly with agencies and managed-service partners to ensure adherence to Alnylam tools, standards, timelines, and quality expectations.
  • Support onboarding and enablement of regional teams by providing practical guidance, documentation, and best practices for publishing execution.
  • Identify recurring execution challenges and propose pragmatic improvements that increase reliability and scalability across global markets.

Requirements

  • Bachelor’s degree in Information Systems, Computer Science, Digital Media, Engineering, or a related technical or systems-oriented field. Advanced degree a plus.
  • 7–10+ years of experience supporting enterprise CMS and digital publishing platforms in regulated environments.
  • Hands-on experience executing and supporting CMS platforms such as AEM, Sitecore, or Drupal.
  • Practical experience with publishing workflows, permissions, templates, metadata, QA, and release coordination.
  • Experience supporting globally deployed platforms, with an understanding of how workflows and governance must scale across markets with differing regulatory and operational requirements.
  • Experience working with DAM platforms in partnership with marketing operations to enable asset reuse.
  • Experience partnering effectively with IT on releases, incidents, and validation while maintaining clear role boundaries.
  • U.S. Pay Range text not a requirement; compensation section covers this.

Preferred

  • Background in pharma or biotech preferred; experience in consumer packaged goods, consumer technology, or other scaled digital environments is an advantage but not required.

Benefits

  • Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k) with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave.
Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

3.5 Glassdoor

SILENCE DISEASE. AMPLIFY LIFE.TMAlnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.See our social media community guidelines: https://bit.ly/2FcRhJy.Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861Fraudulent Recruitment ActivityBe aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Founded in 2002
Cambridge, Massachusetts, USA
2.7K employees (134 in marketing)
62% recommend to a friend
83% CEO approval

Traffic Signals

Monthly Visitors
71.2K
Traffic Source Mix
Search
50.9%
Direct
37%
Referral
9.2%
Social
2.2%
Paid
0.6%

Headcount Trend

Current headcount: ~2.7K

Marketing Team

Marketing Team Size
122 (4% of company)
Median Career Experience
15 years
Median Tenure
2.8 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$4.5B
Last Raise
$661.3M
Post IPO Debt, 6 months ago

Funding History

  • Sep 2025
    Post IPO Debt • $661.3M
  • Sep 2022
    Post IPO Debt • $900M
  • Apr 2020
    Post IPO Debt • $750M

Recent News